⟵ Back to Search Results

BGB-900-101

Terminated

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

Beigene Study ID info

BGB-900-101

ClinicalTrials.gov ID info

NCT03379259

EudraCT Number info

2018-000265-37

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan